Global vaccine production

Global vaccine output remains highly concentrated among a few major producers. Here’s a snapshot of the latest estimates: (Note: Many companies do not publish per‑vaccine production figures; numbers marked with “~” are best estimates derived from procurement data, company statements, and published reports.) See our infographic as a summary. New and emerging highlights SII’s R21/Matrix‑M malaria vaccine now exceeds 40 million doses delivered; its price was recently reduced to $2.99 per dose under a new GAVI/UNICEF agreement. Sanofi’s Beyfortus (nirsevimab, for RSV prevention) has already protected more than 11 million infants across 45+ countries. The Institut Pasteur de Dakar’s new MADIBA facility in Senegal is under construction, with a planned capacity of 300 million doses per year Top vaccine producers by annual dose volume Serum Institute of India (SII) remains the world’s largest vaccine manufacturer. Its measles/rubella vaccine accounts for about 500 million doses per year, covering roughly 90% of UNICEF’s global measles supply. Sanofi continues to...